Maternal Health and Wellbeing

IMPROVE

IMPROVE Start and End dates: 2016 to 2020 Source of Funding: DFID/MRC/Wellcome Trust and European and Developing Countries Clinical Trials Partnership (EDCTP) ($1.8m) The overall aim of the study is to provide the WHO with definitive evidence to determine whether...

IMPROVE2

IMPROVE 2 IPTp with dihydroartemisinin-piperaquine and single-course azithromycin for malaria, sexually transmitted and reproductive tract infections in HIV-infected pregnant women in Kenya and Malawi: a multi-centre, 3-arm placebo-controlled trialStart and End dates:...

REVAMP

REVAMP Randomized controlled trial of the effect of intravenous iron on anemia in Malawian pregnant women Start and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($1.6 million) An individual-randomized Phase III, open-label clinical...

REVAMP Accept

REVAMP Accept Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Feasibility and AcceptabilityStart and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($20,000)This is a...

REVAMP Observe

REVAMP Observe Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Observation CohortStart and End dates: 2018 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($0.75 million)This is a cohort...

REVAMP TT

REVAMP TT Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Third TrimesterStart and End dates: 2020 to 2024 Source of Funding: Bill & Melinda Gates Foundation ($4.6 million)This is an open-label clinical...

Subscribe to Our Newsletter

Stay up to date with developments from Training Research Unit of Excellence